Table 3.
Graft Failure Rates
| Study | Auto | Allo | Total |
|---|---|---|---|
| Peterson et al., 200134 | 1/30 (3.3%) | 1/30 (3.3%) | 2/60 (3.3%) |
| Kustos et al., 200431 | 1/26 (3.8%) | 2/53 (3.8%) | 3/79 (3.8%) |
| Barrett et al., 200528 | 0/25 (0%) | 1/38 (2.6%) | 1/63 (1.6%) |
| Edgar et al., 200829 | 3/37 (8.1%) | 2/46 (4.3%) | 5/83 (6.0%) |
| Sun et al., 20099 | 2/33 (6.1%) | 3/34 (8.8%) | 5/67 (7.5%) |
| Guo et al., 201212 | 0/41 (0%) | 0/33 (0%) | 0/74 (0%) |
| Lawhorn et al., 201221 | 0/74 (0%) | 0/73 (0%) | 0/147 (0%) |
| Barber et al., 201427 | 5/53 (9.4%) | 2/28 (7.1%) | 7/81 (8.6%) |
| Bottoni et al., 201520 | 4/48 (8.3%) | 13/49 (26.5%) | 17/97 (17.5%) |
| Yoo et al., 201725 | 1/68 (1.5%) | 1/64 (1.6%) | 2/132 (1.5%) |
| Tian et al., 201624 | 0/62 (0%) | 0/59 (0%) | 0/121 (0%) |
| Kane et al., 201630 | 1/60 (1.7%) | 12/59 (20.3%) | 13/119 (10.9%) |
| Maletis et al., 201732 | 85/4,557 (1.9%) | 5/155 (3.2%) | 90/4,712 (1.9%) |
| Maletis et al., 201733 | 217/10,264 (2.1%) | 12/729 (1.6%) | 229/10,993 (2.1%) |
NOTE. Each cell includes the number of graft failures/total number of ACLRs performed (%) within each group.
ACLR, anterior cruciate ligament reconstruction; Allo, nonirradiated allograft; Auto, autograft.